Heterochromatin protein 1 expression is reduced in human thyroid malignancy

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Thyroid tumorigenesis involves loss of heterochromatin integrity.
• Heterochromatin Protein 1 (HP1) isoforms, including HP1α and HP1β, are crucial for maintaining chromatin structure.
• Alterations in HP1 expression are implicated in various cancers.

Purpose of the Study:

• To investigate the expression levels of HP1α and HP1β in thyroid tumors.
• To determine the correlation between HP1 expression and clinicopathological features of thyroid lesions.
• To explore the potential role of microRNAs in regulating HP1β expression during thyroid carcinogenesis.

Main Methods:

• Immunohistochemistry was performed on 189 thyroid tumors and non-neoplastic tissues.
• Expression levels of HP1α and HP1β were quantified.
• Correlation analysis was conducted between HP1 expression and tumor characteristics.
• The role of miR-205 in regulating HP1β was investigated.

Main Results:

• HP1β expression was significantly decreased in most thyroid lesions compared to normal tissue, with the exception of follicular adenomas.
• miR-205 was found to be upregulated in thyroid carcinomas and can reduce HP1β expression.
• HP1α expression was reduced only in metastatic and poorly differentiated carcinomas.
• Loss of HP1β and HP1α expression correlates with thyroid malignancy and metastatic potential.

Conclusions:

• Reduced expression of HP1β, potentially mediated by microRNA dysregulation, is an early event in thyroid tumorigenesis.
• The sequential loss of HP1β followed by HP1α contributes to thyroid carcinoma development and progression.
• Decreased HP1β and HP1α serve as potential biomarkers for thyroid malignancy and metastatic capability.